Scarica l'app Stockscreener
30.80
4.42%
-1.43
Dopo l'orario di chiusura:
30.95
0.15
+0.49%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALKS Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$32.23
Aprire:
$32.11
Volume 24 ore:
2.23M
Relative Volume:
1.16
Capitalizzazione di mercato:
$5.08B
Reddito:
$1.51B
Utile/perdita netta:
$333.35M
Rapporto P/E:
15.79
EPS:
1.95
Flusso di cassa netto:
$315.22M
1 W Prestazione:
-1.83%
1M Prestazione:
+12.47%
6M Prestazione:
+13.25%
1 anno Prestazione:
+9.67%
Intervallo 1D:
$30.40
$32.29
Intervallo di 1 settimana:
$30.40
$32.40
Portata 52W:
$25.16
$36.45
Alkermes Plc Stock (ALKS) Company Profile
Nome
Alkermes Plc
Settore
Telefono
00-353-1-772-8000
Indirizzo
CONNAUGHT HOUSE, DUBLIN 4
Confronta ALKS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALKS
Alkermes Plc
|
30.80 | 5.27B | 1.51B | 333.35M | 315.22M | 1.95 |
|
ZTS
Zoetis Inc
|
143.24 | 63.58B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.89 | 43.58B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.185 | 40.83B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.62 | 23.07B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
432.69 | 19.61B | 3.08B | 1.24B | 1.07B | 25.61 |
Alkermes Plc Stock (ALKS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-26 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-09-03 | Iniziato | Wells Fargo | Overweight |
| 2025-07-15 | Iniziato | Goldman | Buy |
| 2025-06-17 | Aggiornamento | UBS | Neutral → Buy |
| 2025-05-28 | Iniziato | Needham | Buy |
| 2025-03-13 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2025-03-04 | Aggiornamento | UBS | Sell → Neutral |
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2024-11-05 | Aggiornamento | Stifel | Hold → Buy |
| 2024-06-17 | Iniziato | TD Cowen | Buy |
| 2024-03-19 | Iniziato | Robert W. Baird | Outperform |
| 2024-02-20 | Downgrade | UBS | Neutral → Sell |
| 2023-11-20 | Ripresa | JP Morgan | Neutral |
| 2023-10-24 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-10-17 | Iniziato | UBS | Neutral |
| 2022-11-03 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-10-14 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-08-16 | Iniziato | Piper Sandler | Neutral |
| 2022-04-22 | Ripresa | Goldman | Buy |
| 2022-04-20 | Iniziato | Goldman | Buy |
| 2022-01-27 | Aggiornamento | Cantor Fitzgerald | Hold → Overweight |
| 2021-12-01 | Iniziato | Citigroup | Neutral |
| 2021-10-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-09-02 | Downgrade | BofA Securities | Neutral → Underperform |
| 2020-10-15 | Aggiornamento | Mizuho | Neutral → Buy |
| 2020-07-30 | Downgrade | Goldman | Neutral → Sell |
| 2020-02-14 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2020-02-14 | Reiterato | H.C. Wainwright | Neutral |
| 2020-02-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-02-06 | Iniziato | Mizuho | Neutral |
| 2020-01-31 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2019-09-05 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2019-07-15 | Aggiornamento | Goldman | Sell → Neutral |
| 2019-05-31 | Iniziato | H.C. Wainwright | Neutral |
| 2019-05-01 | Downgrade | Citigroup | Buy → Neutral |
| 2018-12-19 | Downgrade | Goldman | Neutral → Sell |
| 2018-12-14 | Iniziato | Wolfe Research | Underperform |
| 2018-12-13 | Downgrade | Credit Suisse | Outperform → Underperform |
| 2018-11-05 | Iniziato | Piper Jaffray | Neutral |
| 2018-08-07 | Iniziato | Stifel | Hold |
| 2018-06-21 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2018-06-06 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2018-05-16 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-05-11 | Iniziato | BofA/Merrill | Buy |
Mostra tutto
Alkermes Plc Borsa (ALKS) Ultime notizie
Alkermes EVP Hopkinson sells $283,776 in shares - Investing.com India
Order flow analysis tools used on Alkermes plcWeekly Risk Report & Target Return Focused Picks - newser.com
Why Alkermes plc stock appeals to analystsMarket Trend Report & Real-Time Price Movement Reports - newser.com
Can Alkermes plc stock deliver consistent earnings growthNew Guidance & Free Real-Time Volume Trigger Notifications - newser.com
Earnings call transcript: Alkermes Plc forecasts strong proprietary sales in Q2 2025 - Investing.com Australia
Real time breakdown of Alkermes plc stock performanceJuly 2025 PreEarnings & Low Risk High Reward Ideas - newser.com
What technical models suggest about Alkermes plc’s comeback2025 Buyback Activity & Long Hold Capital Preservation Tips - newser.com
Is Alkermes plc (8AK) stock cheap vs fundamentalsJuly 2025 Catalysts & Risk Controlled Stock Pick Alerts - newser.com
Is Alkermes plc (8AK) stock at risk of policy regulationJuly 2025 Momentum & Accurate Entry and Exit Point Alerts - newser.com
Historical volatility pattern of Alkermes plc visualized2025 Geopolitical Influence & AI Driven Price Predictions - newser.com
What analysts say about Alkermes plc 8AK stockInstitutional Buying Trends & Next-Level Stock Intelligence, Now Free - earlytimes.in
Is Alkermes plc stock reversal real or fakeJuly 2025 Spike Watch & Accurate Buy Signal Alerts - newser.com
Alkermes Plc (ALKS) Stock Analysis: Investor Outlook With A 33.82% Potential Upside - DirectorsTalk Interviews
Is now a turning point for Alkermes plcQuarterly Portfolio Summary & Trade Opportunity Analysis - newser.com
Full technical analysis of Alkermes plc stock2025 Volume Leaders & Long-Term Capital Growth Ideas - newser.com
Is Alkermes plc a good long term investmentDouble Top/Bottom Patterns & Identify Safe Investments - earlytimes.in
Can Alkermes plc stock deliver strong Q4 earningsMarket Risk Summary & Fast Moving Market Watchlists - newser.com
Ranking Alkermes plc among high performing stocks via toolsJuly 2025 Movers & Comprehensive Market Scan Insights - newser.com
Alkermes Plc Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo
How cyclical is Alkermes plc (8AK) stock compared to rivalsEarnings Overview Report & Fast Gaining Stock Strategy Reports - newser.com
Pattern recognition hints at Alkermes plc upside2025 Stock Rankings & Daily Market Momentum Tracking - newser.com
Will Alkermes plc (8AK) stock hit Wall Street targetsProduct Launch & AI Powered Market Entry Ideas - newser.com
Is Alkermes Plc (NASDAQ:ALKS) Trading At A 43% Discount? - 富途牛牛
Alkermes upgraded at RBC Capital Markets ahead of key catalyst - MSN
RBC Lifts Price Target on Alkermes to $45 From $44, Keeps Outperform Rating - MarketScreener
Do Options Traders Know Something About Alkermes Stock We Don't? - Yahoo Finance
Robeco Institutional Asset Management B.V. Buys 36,467 Shares of Alkermes plc $ALKS - MarketBeat
Substance Abuse Treatment Market Size, Growth Analysis 2031 - openPR.com
Is Alkermes plc reversing from oversold territoryTrade Risk Assessment & Reliable Breakout Stock Forecasts - newser.com
Technical analysis overview for Alkermes plc stockMarket Weekly Review & Fast Exit/Entry Strategy Plans - newser.com
Alkermes Plc Experiences Evaluation Revision Amidst Mixed Market Signals and Performance Trends - Markets Mojo
Alkermes sued over alleged scheme to block generic Vivitrol - Reuters
Will Alkermes plc (8AK) stock benefit from Fed rate cuts2025 Market Overview & Comprehensive Market Scan Insights - newser.com
What candlestick patterns are forming on Alkermes plcJuly 2025 Patterns & Fast Gain Stock Trading Tips - newser.com
Alkermes Plc Azioni (ALKS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Alkermes Plc Azioni (ALKS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer |
Oct 15 '25 |
Sale |
31.53 |
9,000 |
283,776 |
73,740 |
0.02%
5.80%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):